Curcumin prevents formation of polyglutamine aggregates by inhibiting Vps36, a component of the ESCRT-II complex.

Small molecules with antioxidative properties have been implicated in amyloid disorders. Curcumin is the active ingredient present in turmeric and known for several biological and medicinal effects. Adequate evidence substantiates the importance of curcumin in Alzheimer's disease and recent evi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Meenakshi Verma, Abhishek Sharma, Swarna Naidu, Ankan Kumar Bhadra, Ritushree Kukreti, Vibha Taneja
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b90d63209fc649be9ea259f4be9de01b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b90d63209fc649be9ea259f4be9de01b
record_format dspace
spelling oai:doaj.org-article:b90d63209fc649be9ea259f4be9de01b2021-11-18T07:09:24ZCurcumin prevents formation of polyglutamine aggregates by inhibiting Vps36, a component of the ESCRT-II complex.1932-620310.1371/journal.pone.0042923https://doaj.org/article/b90d63209fc649be9ea259f4be9de01b2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22880132/?tool=EBIhttps://doaj.org/toc/1932-6203Small molecules with antioxidative properties have been implicated in amyloid disorders. Curcumin is the active ingredient present in turmeric and known for several biological and medicinal effects. Adequate evidence substantiates the importance of curcumin in Alzheimer's disease and recent evidence suggests its role in Prion and Parkinson's disease. However, contradictory effects have been suggested for Huntington's disease. This difference provided a compelling reason to investigate the effect of curcumin on glutamine-rich (Q-rich) and non-glutamine-rich (non Q-rich) amyloid aggregates in the well established yeast model system. Curcumin significantly inhibited the formation of htt72Q-GFP (a Q-rich) and Het-s-GFP (a non Q-rich) aggregates in yeast. We show that curcumin prevents htt72Q-GFP aggregation by down regulating Vps36, a component of the ESCRT-II (Endosomal sorting complex required for transport). Moreover, curcumin disrupted the htt72Q-GFP aggregates that were pre-formed in yeast and cured the yeast prion, [PSI(+)].Meenakshi VermaAbhishek SharmaSwarna NaiduAnkan Kumar BhadraAnkan Kumar BhadraRitushree KukretiVibha TanejaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 8, p e42923 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Meenakshi Verma
Abhishek Sharma
Swarna Naidu
Ankan Kumar Bhadra
Ankan Kumar Bhadra
Ritushree Kukreti
Vibha Taneja
Curcumin prevents formation of polyglutamine aggregates by inhibiting Vps36, a component of the ESCRT-II complex.
description Small molecules with antioxidative properties have been implicated in amyloid disorders. Curcumin is the active ingredient present in turmeric and known for several biological and medicinal effects. Adequate evidence substantiates the importance of curcumin in Alzheimer's disease and recent evidence suggests its role in Prion and Parkinson's disease. However, contradictory effects have been suggested for Huntington's disease. This difference provided a compelling reason to investigate the effect of curcumin on glutamine-rich (Q-rich) and non-glutamine-rich (non Q-rich) amyloid aggregates in the well established yeast model system. Curcumin significantly inhibited the formation of htt72Q-GFP (a Q-rich) and Het-s-GFP (a non Q-rich) aggregates in yeast. We show that curcumin prevents htt72Q-GFP aggregation by down regulating Vps36, a component of the ESCRT-II (Endosomal sorting complex required for transport). Moreover, curcumin disrupted the htt72Q-GFP aggregates that were pre-formed in yeast and cured the yeast prion, [PSI(+)].
format article
author Meenakshi Verma
Abhishek Sharma
Swarna Naidu
Ankan Kumar Bhadra
Ankan Kumar Bhadra
Ritushree Kukreti
Vibha Taneja
author_facet Meenakshi Verma
Abhishek Sharma
Swarna Naidu
Ankan Kumar Bhadra
Ankan Kumar Bhadra
Ritushree Kukreti
Vibha Taneja
author_sort Meenakshi Verma
title Curcumin prevents formation of polyglutamine aggregates by inhibiting Vps36, a component of the ESCRT-II complex.
title_short Curcumin prevents formation of polyglutamine aggregates by inhibiting Vps36, a component of the ESCRT-II complex.
title_full Curcumin prevents formation of polyglutamine aggregates by inhibiting Vps36, a component of the ESCRT-II complex.
title_fullStr Curcumin prevents formation of polyglutamine aggregates by inhibiting Vps36, a component of the ESCRT-II complex.
title_full_unstemmed Curcumin prevents formation of polyglutamine aggregates by inhibiting Vps36, a component of the ESCRT-II complex.
title_sort curcumin prevents formation of polyglutamine aggregates by inhibiting vps36, a component of the escrt-ii complex.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/b90d63209fc649be9ea259f4be9de01b
work_keys_str_mv AT meenakshiverma curcuminpreventsformationofpolyglutamineaggregatesbyinhibitingvps36acomponentoftheescrtiicomplex
AT abhisheksharma curcuminpreventsformationofpolyglutamineaggregatesbyinhibitingvps36acomponentoftheescrtiicomplex
AT swarnanaidu curcuminpreventsformationofpolyglutamineaggregatesbyinhibitingvps36acomponentoftheescrtiicomplex
AT ankankumarbhadra curcuminpreventsformationofpolyglutamineaggregatesbyinhibitingvps36acomponentoftheescrtiicomplex
AT ankankumarbhadra curcuminpreventsformationofpolyglutamineaggregatesbyinhibitingvps36acomponentoftheescrtiicomplex
AT ritushreekukreti curcuminpreventsformationofpolyglutamineaggregatesbyinhibitingvps36acomponentoftheescrtiicomplex
AT vibhataneja curcuminpreventsformationofpolyglutamineaggregatesbyinhibitingvps36acomponentoftheescrtiicomplex
_version_ 1718423877058560000